Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/4KB stock hub

FRA/4KB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/4KBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.7B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/4KB

In the news

Latest news · FRA/4KB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E32.2

P25 n/aP50 n/aP75 n/a

Trailing P/E39.2

P25 n/aP50 n/aP75 n/a

ROE19.9

P25 n/aP50 n/aP75 n/a

ROIC41.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/4KB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

187

Groups with data

Currency

USD

Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	295
Employees Change	46%
Employees Change Percent	20.09
Enterprise value	EUR 6.8B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 7.7B
Price	EUR 256
Price currency	EUR
Rev Per Employee	1,226,873.76x
Sic	2836
Symbol	fra/4KB
Website	https://www.krystalbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.55%
EV Earnings	34.84x
EV/EBIT	44.78x
EV/EBITDA	43.92x
EV/FCF	33.03x
EV/Sales	19.18x
FCF yield	2.69%
Forward P/E	32.22x
P/B ratio	6.91x
P/E ratio	39.23x
P/S ratio	21.16x
PE Ratio3 Y	77.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	42.83%
EBITDA Margin	43.25%
FCF margin	56.88%
Gross margin	94.17%
Gross Profit	EUR 340.8M
Gross Profit Growth	26.44%
Gross Profit Growth Q	32.32%
Net Income	EUR 195.2M
Net Income Growth	81.53%
Net Income Growth Q	56.53%
Pretax Margin	49.68%
Profit Margin	53.92%
Profit Per Employee	EUR 661,588
ROA	9.04
Roa5y	-3.12
ROCE	13.86
ROE	19.9
Roe5y	-1.97
ROIC	41.4
Roic5y	-23.48

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	109.67%
Cagr3y	50.3%
Cagr5y	34.86%
EPS Growth	79.7
EPS Growth Q	52.5
FCF Growth	83.56%
FCF Growth Q	195.72%
OCF Growth	80.71%
OCF Growth Q	159.56%
Revenue Growth	25.15x
Revenue Growth Q	31.95x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.34
Assets	EUR 1.2B
Cash	EUR 714.1M
Current Assets	EUR 864.7M
Current Liabilities	EUR 91.4M
Debt	EUR 7.9M
Debt EBITDA	EUR 0.05
Debt Equity	EUR 0.01
Debt FCF	EUR 0.04
Equity	EUR 1.1B
Liabilities	EUR 104.3M
Long Term Assets	EUR 346.9M
Long Term Liabilities	EUR 12.9M
Net Cash	EUR 874M
Net Cash By Market Cap	EUR 11.42
Net Cash Growth	33.36%
Net Debt EBITDA	EUR -5.58
Net Debt Equity	EUR -0.79
Net Debt FCF	EUR -4.25
Tangible Book Value	EUR 1.1B
Tangible Book Value Per Share	EUR 37.62

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.46
Inventory Turnover	0.67
Net Working Capital	EUR 78.3M
Quick ratio	8.82
Working Capital	EUR 790.9M
Working Capital Turnover	EUR 0.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	109.56%
200-day SMA	187.2
3Y total return	239.6%
50-day SMA	224.9
50-day SMA vs 200-day SMA	50over200
5Y total return	345.91%
All Time High	258.2
All Time High Change	-0.7%
All Time High Date	2026-05-08
All Time Low	34.4
All Time Low Change	645.35%
All Time Low Date	2021-11-29
ATR	5.31
Ch YTD	19.7
High	258.2
High52	258.2
High52 Date	2026-05-08
High52ch	0%
Low	250.7
Low52	108.4
Low52 Date	2025-06-03
Low52ch	136.53%
Ma50ch	14%
Price vs 200-day SMA	36.94%
RSI	68.31
RSI Monthly	69.25
RSI Weekly	72.44
Sharpe ratio	1.93x
Sortino ratio	3.03
Total Return	-0.75%
Tr YTD	19.7
Tr1m	13.96%
Tr1w	13.45%
Tr3m	13.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 155M
Operating Income Growth	33.7
Operating Income Growth Q	48.1
Operating margin	42.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	23,369,649%
Shares Insiders	10.42%
Shares Institutions	87.7%
Shares Qo Q	0.85%
Shares Yo Y	0.75%
Short Ratio	9.85

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 158.5M
Average Volume	2.4x
Bv Per Share	37.62
CAPEX	EUR -11.2M
Ch1m	13.96
Ch1w	13.45
Ch1y	109.6
Ch3m	13.65
Ch3y	239.6
Ch5y	345.9
Ch6m	48.51
Change	7.82%
Change From Open	1.22
Close	237.8
Days Gap	6.52
Depreciation Amortization	1,472,062
Earnings Date	2026-05-04
EBIT	EUR 155M
EBITDA	EUR 156.5M
EPS	EUR 6.48
F Score	5
FCF	EUR 205.9M
FCF EV Yield	3.03x
Financing CF	9,290,518
Fiscal Year End	December
Founded	2,016
Graham Number	73.84144
Graham Upside	-71.2
Income Tax	EUR -15.4M
Investing CF	-58,309,446
Is Primary Listing	0
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Ma150	207
Ma150ch	23.89%
Ma20	231.1
Ma20ch	10.96%
Net CF	166,992,544
Open	253.3
P FCF Ratio	37.19
P OCF Ratio	35.27
Position In Range	76
Ppne	136,197,112.6
Price Date	2026-05-08
Price EBITDA	EUR 48.92
Ptbv Ratio	6.91
Relative Volume	79.09x
Revenue	361,927,759x
SBC By Revenue	13.09x
Share Based Comp	47,393,609
Tax By Revenue	-4.24x
Tr6m	48.51%
Volume	0
Z Score	29.48

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/4KB pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/4KB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/4KB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+87.7%

Share of float held by funds and institutions

Insider ownership

+10.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/4KB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

68.3

Neutral momentum band

Price vs 200-day MA

+36.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.93

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/4KB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/4KB stock rating?

fra/4KB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/4KB analysis?

The full report lives at /stocks/fra/4KB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/4KB?

The latest report frames fra/4KB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/4KB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.